ACRO BIOMEDICAL CO., LTD. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2015 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Acro Biomedical Co., Ltd. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2015 to Q2 2023.
  • Acro Biomedical Co., Ltd. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2023 was -$3.2M, a 20% increase year-over-year.
  • Acro Biomedical Co., Ltd. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2023 was -$15.1M, a 2.55% decline year-over-year.
  • Acro Biomedical Co., Ltd. annual Net Income (Loss) Attributable to Parent for 2022 was -$15.9M, a 106% decline from 2021.
  • Acro Biomedical Co., Ltd. annual Net Income (Loss) Attributable to Parent for 2021 was -$7.7M, a 6454% decline from 2020.
  • Acro Biomedical Co., Ltd. annual Net Income (Loss) Attributable to Parent for 2020 was -$117K, a 68.4% increase from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 -$15.1M -$3.2M +$801K +20% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$15.9M -$4M -$75.6K -1.92% Jan 1, 2023 Mar 31, 2023 10-Q 2023-08-14
Q4 2022 -$15.9M -$3.93M -$81.9K -2.13% Oct 1, 2022 Dec 31, 2022 10-K 2023-07-21
Q3 2022 -$15.8M -$4.01M -$1.02M -34.1% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-21
Q2 2022 -$14.8M -$4M -$3.2M -403% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$11.6M -$3.93M -$3.87M -6504% Jan 1, 2022 Mar 31, 2022 10-Q 2023-08-14
Q4 2021 -$7.7M -$3.85M -$3.79M -6137% Oct 1, 2021 Dec 31, 2021 10-K 2023-07-21
Q3 2021 -$3.91M -$2.99M -$2.92M -3991% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-21
Q2 2021 -$989K -$795K -$731K -1148% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-21
Q1 2021 -$258K -$59.5K -$141K -173% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-21
Q4 2020 -$117K -$61.8K +$14.1K +18.6% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-15
Q3 2020 -$132K -$73.1K +$2.06K +2.74% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-22
Q2 2020 -$134K -$63.7K -$12.9K -25.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-22
Q1 2020 -$121K $81.1K +$251K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-24
Q4 2019 -$372K -$75.9K -$857 -1.14% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-02
Q3 2019 -$371K -$75.2K -$229K -149% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-17
Q2 2019 -$142K -$50.8K -$167K -144% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-17
Q1 2019 $25.2K -$170K -$239K -344% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-17
Q4 2018 $264K -$75K -$155K -194% Oct 1, 2018 Dec 31, 2018 10-K 2021-04-02
Q3 2018 $420K $154K +$114K +289% Jul 1, 2018 Sep 30, 2018 10-KT 2020-03-27
Q2 2018 $305K $116K +$128K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $177K $69.5K +$91.9K Jan 1, 2018 Mar 31, 2018 10-Q 2019-08-14
Q4 2017 $85.4K $80.2K +$87.6K Oct 1, 2017 Dec 31, 2017 10-Q 2019-08-14
Q3 2017 -$2.25K $39.5K +$45.6K Jul 1, 2017 Sep 30, 2017 10-K 2018-12-28
Q2 2017 -$47.9K -$11.9K +$5.24K +30.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$53.1K -$22.4K -$16.1K -253% Jan 1, 2017 Mar 31, 2017 10-Q 2018-08-01
Q4 2016 -$37K -$7.41K +$6.41K +46.4% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-14
Q3 2016 -$43.4K -$6.13K Jul 1, 2016 Sep 30, 2016 10-K/A 2018-01-16
Q2 2016 -$17.1K -$17.1K -95039% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 -$6.35K -$6.32K -21797% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-22
Q4 2015 -$13.8K Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-14
Q2 2015 -$18* Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-03
Q1 2015 -$29* Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.